Market Research

Page last updated: 16 December 2016

The Department commissioned ORC International to conduct a quantitative research study to obtain a quantitative baseline measure of awareness, knowledge and intentions around biosimilar medicines. The outcomes of this research have informed the development of communication strategies and educational materials for the Biosimilar Awareness Initiative. The key target audiences for the research were:

  • Specialists who are potential prescribers of biological and biosimilar medicines;
  • General practitioners who are potential prescribers of biological and biosimilar medicines;
  • Community pharmacists who are potential dispensers of biological and biosimilar medicines and advisors to patients; and
  • Patients with associated conditions and their carers.
Overall, the research showed that professional stakeholders (specialists, general practitioners and pharmacists) had much higher levels of knowledge of biological and biosimilar medicines compared to consumers. As a whole, consumers had a lower familiarity of biosimilar medicines than biologic medicines. All professional stakeholders were more likely to see potential benefits to prescribing biosimilar medicines than potential barriers.

You can access a copy of the Research report:

Research Report (PDF 2521 KB)
Research Report (Word 3036 KB)

In this section